Ron Sherman

Content from this Writer

Maggot Debridement Therapy
June 20th, 2019

By Ronald A. Sherman, MD

The year 2019 began with a shadow over the field of biosurgery and a dark cloud over American health care: BioMonde, currently the largest producer of medicinal maggots in the world, just closed its American laboratory. Most famous for its dressing...

road blocks to maggot debridement therapy
June 23rd, 2017

By Ronald Sherman MD, MSC, DTM&H

Bob Hope and Bing Crosby starred in a series of films called "On the Road" in which the duo traveled around the globe, facing a variety of amusing obstacles and mishaps. Therapists and patients desiring maggot debridement therapy (MDT) for...

wound care conference speaker
August 21st, 2016

By Ronald Sherman MD, MSC, DTM&H

I am seeing more and more expert lecturers being disqualified from speaking at wound care conferences, simply because their qualifications include significant positions or associations in the corporate world. When did these speakers'...

determining when to use contained maggot therapy
February 25th, 2016

By Ronald Sherman MD, MSC, DTM&H

In a previous post, we learned that all clinical studies to date and all but one laboratory study indicate that contained ("bagged") maggots are effective in wound debridement, but less so than "free-range" (or "non-bagged") larvae. Why, then...

Clinical Research
December 17th, 2015

By Ron Sherman MD, MSC, DTM&H

In my previous post on maggot therapy, we discussed the differences between confinement and containment maggot therapy dressings. This post will examine the studies that address differences in efficacy and efficiency between these two methods of...

Leflap maggot dressing in action
August 27th, 2015

By Ron Sherman MD, MSC, DTM&H

I have been avoiding the topic of addressing the differences between contained (bagged) versus confined (non-bagged or "free-range") maggot therapy because I haven't wanted to take a position in affairs that affect specific companies' products....

June 4th, 2015

By Ron Sherman MD, MSC, DTM&H

Several months back, I suggested that we could better understand our patients' actions (for example, why patients do not adhere to their treatment plans) by looking at the situation from the patient's perspective. What I failed to discuss –...

October 14th, 2014

By Ron Sherman MD, MSC, DTM&H

My thoughts today do not center on biotherapy or even wound care. They center on the concept of perspective. But perspective really affects every aspect of life, including wound care. The ability (or, better yet, the habit) of adjusting our...

June 20th, 2014

By Deboshree Roy, MSC and Ron Sherman MD, MSC, DTM&H

Most wound care therapists are well acquainted with the benefits of maggot debridement therapy (MDT) by now, but may not be as informed about its adverse events. As an intern with the BTER Foundation, one of my projects was...

February 12th, 2014

By Ron Sherman MD, MSC, DTM&H

The Primary Issues with Systematic Reviews

My contribution to this column is very much overdue. Among other things, I have spent much of my time this past 12 months preparing to write my first "systematic review." The experience has...

July 12th, 2013

By Ron Sherman MD, MSC, DTM&H and Lynn Wang, BA

William Shakespeare wrote: "That which we call a rose, by any other name, would smell as sweet" (Romeo and Juliet, Act 2, Scene 2). William Baer reportedly said the same thing when asked why he used the name "...

May 10th, 2013

By Ron Sherman MD, MSC, DTM&H and Lynn Wang, BA

Warning: Information ahead. Read responsibly. Consume with caution.

February 27th, 2013

By Ron Sherman MD, MSC, DTM&H

Over 80 years ago, Dr. William Baer — then Chair of Orthopedic Surgery at Johns Hopkins — observed that wounds debrided with...

October 19th, 2012

By Ron Sherman MD, MSC, DTM&H

Two hundred years ago, Joseph Joubert wrote: “To teach is to learn twice.” For me, preparing for a lecture or workshop is like learning the latest information all over again. But giving the lecture and pondering over the students’ questions is...

September 6th, 2012

By Ron Sherman MD, MSC, DTM&H

Like Rodney Dangerfield, maggot therapy sometimes gets no respect. Take, for example, the following comment which appeared on the WoundSource Facebook page, in response to a post...

May 18th, 2012

By Ron Sherman MD, MSC, DTM&H

This week I was asked about using maggot therapy for treating a tumor that eroded through the skin, causing a foul-smelling, necrotic draining wound. This is not an uncommon question...

March 29th, 2012

By Ron Sherman MD, MSC, DTM&H

Numerous controlled studies of maggot therapy have been published during the past 20 years, each one demonstrating equality or...

December 8th, 2011

By Ron Sherman MD, MSC, DTM&H

As far back as 1930, clinicians and researchers had a pretty good understanding of what “the right kind of maggots” could do for a wound. Those maggots are now known generically as “medicinal maggots” or “medical grade maggots.” Largely as the...

September 26th, 2011

By Ron Sherman MD, MSC, DTM&H

Although maggot therapy has been with us for nearly 100 years, many wound care specialists are still unfamiliar with it. Therefore, we should step...

July 18th, 2011

By Ron Sherman MD, MSC, DTM&H

This being the first in a series of WoundSource blogs about biotherapies, it seems appropriate to use this opportunity to define the discipline of biotherapy. After all, even within the biotherapy...